AdAlta is a groundbreaking biotechnology company that has developed a revolutionary platform for creating unique compounds called i-bodies. These compounds are created by mimicking the shape and stability features of shark antibodies into human proteins, creating a powerful tool for therapeutic intervention in a variety of diseases. AdAlta is at the forefront of this cutting-edge technology and is poised to make a major impact on the world of biotechnology and pharmaceuticals. With their innovative approach and commitment to developing transformative solutions, AdAlta is a company to watch in the years ahead.